openPR Logo
Press release

Diabetic Retinopathy - Drug Pipeline Landscape, 2022

12-20-2022 03:35 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global insight services

New York, Global Diabetic Retinopathy Drug Pipeline Landscape report from Global Insight Services is the single authoritative source of intelligence on Diabetic Retinopathy Drug Pipeline Landscape. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Diabetic Retinopathy - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/diabetic-retinopathy-drug-pipeline-landscape-2022/

Diabetic retinopathy is a censorious medical disorder that affects the eyes due to inefficient insulin level in the blood of the patient. A high sugar level in the blood causes blockage of the retina's small blood capillaries, impeding blood flow resulting in cloudy or blurred vision there are two types of diabetic retinopathy non-proliferative diabetic retinopathy and proliferative diabetic retinopathy.

A high sugar level in the blood causes blockage of the retina's small blood capillaries and impairment to blood vessels of the light-sensitive tissue of the retina is the main cause of diabetic retinopathy.

Symptoms of diabetic retinopathy are blurred vision, dark or empty spots in the vision, fluctuating vision, poor colour identification and vision loss.

Diabetic retinopathy is diagnosed by a comprehensive dilated eye exam and Fluorescein angiography.

Diabetic retinopathy is treated by diet modifications and drugs like insulin vascular endothelial growth factor inhibitors and laser treatment, eye surgery.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS31109/

Report Highlights

Global Insight Service's, Diabetic Retinopathy - Drug Pipeline Landscape, 2022 report provides an overview of the Diabetic Retinopathy pipeline drugs. This report covers detailed insights on Diabetic Retinopathy drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Diabetic Retinopathy pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS31109/

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players

Adverum Biotechnologies Inc
Aerie Pharmaceuticals
Afecta Pharmaceuticals Inc
Allergan
Amytrx Therapeutics Inc
AngiosGmbH
AntlerA Therapeutics Inc
Applied Therapeutics Inc
AptaBio
Arctic Vision Shanghai Biotechnology Co Ltd
Aviceda Therapeutics
Avirmax Inc
Ayuvis Research Inc

Get a 50% Off on Purchase of this Report Use Code (GIS2022SUP50):https://www.globalinsightservices.com/checkout/single_user/GIS31109/

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website:https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetic Retinopathy - Drug Pipeline Landscape, 2022 here

News-ID: 2857312 • Views:

More Releases from Global insight services

Helium Gas Market: Expansion Fueled by Increasing Applications in Cryogenics, Aerospace, and Advanced Manufacturing
Helium Gas Market: Expansion Fueled by Increasing Applications in Cryogenics, Ae …
The Helium Gas Market is evolving rapidly as industries worldwide continue to rely on helium for its unique properties, including low boiling point, inertness, and high thermal conductivity. This rare noble gas is essential across healthcare, electronics, aerospace, and scientific research. As technological innovation accelerates, the Helium Gas Market continues to play a vital role by supporting advanced manufacturing processes and critical medical applications. From MRI machines to semiconductor fabrication,
Heavy Lift Helicopters Market: Growth Supported by Adoption of Advanced Rotorcraft for Heavy Cargo and Specialized Missions | Overall Study Report Till 2035
Heavy Lift Helicopters Market: Growth Supported by Adoption of Advanced Rotorcra …
The Heavy-lift Helicopter Market continues to gain traction as industries and defense organizations increasingly rely on advanced aerial transport capabilities. Heavy-lift helicopters are engineered to carry substantial payloads, support remote operations, and enhance mobility across the construction, military, oil and gas, and emergency response sectors. With rising global tensions, expanding infrastructure projects, and rapid modernization of aviation fleets, the Heavy-lift Helicopter Market is entering a phase of strong, technology-driven growth.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Key Players: Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals.
Glp-1 Agonist Market To Surge From $53 BN To $264.9 BN By 2034 At 17.5% Cagr. Ke …
Market Overview GLP-1 Agonist Market is rapidly evolving as the demand for advanced diabetes and obesity treatments continues to rise globally. These drugs, known as glucagon-like peptide-1 receptor agonists, help improve insulin secretion, reduce glucagon levels, and enhance satiety-making them a powerful solution for type 2 diabetes and weight management. With diabetes and obesity reaching unprecedented levels, the GLP-1 Agonist Market stands at the forefront of therapeutic innovation. Growing patient awareness,
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2034 At 6.9% Cagr. Key Players: Activeviam, Sas Risk Management, Fiserv.
Financial Risk Management Software Market To Grow From $24.5 BN To $47.8 BN By 2 …
Market Overview Financial Risk Management Software Market is evolving rapidly as financial institutions and enterprises navigate increasingly complex global uncertainties. With tightening regulations and growing exposure to market volatility, organizations are turning toward advanced digital solutions that help identify, assess, and mitigate financial risks in real time. The Financial Risk Management Software Market integrates AI, machine learning, predictive analytics, and cloud technologies to enhance credit, liquidity, operational, and market risk insights.

All 5 Releases


More Releases for Diabetic

Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025? The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report. On the basis of
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282 Global Diabetic Socks Market: Factors Impacting the Market The primary factors driving the growth of the global diabetic socks market are increasing
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be